Vivos Therapeutics, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Gross
Vivos Therapeutics, Inc. (VVOS) had Stock Issued During Period, Shares, Restricted Stock Award, Gross of 607.29 thousand shares as of 2025-06-10, per its 10-Q filed 2025-08-19.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2025-08-19
- 2025-06-10: Stock Issued During Period, Shares, Restricted Stock Award, Gross 607.29K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross |
|---|---|
| 2025-06-10 | 607.29K shares 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |